´
J. M. Perez et al. / Tetrahedron 56 (2000) 1561–1567
1566
119.4 (C-8a,9a); 112.2 (C-3,6); 44.8 (2 NMe2), 34.9 (C-4,5);
24.6 (2 CH3).
J7.7 and 1.7 Hz, H-4), 7.71 (dd, J7.5 and 4.8 Hz, H-3),
7.58 (s, 1H, H-6).
1,8-bis(dimethylamino)-4,5-diethyl-3,6-dimethyl-1,4,5,8-
7-bromo-3-methyl-5,8-quinolinequinone
(21).
dH
tetrahydro-1,8-diaza-9,10-anthraquinone
(17).
dH
(CDCl3, 250 MHz) 8.76 (d, 1H, J2.0 Hz, H-2), 8.10 (d,
(CDCl3, 250 MHz) 6.08 (s, 2H, H-2,7); 3.47 (t, 2H,
J4.1 Hz, H-4,5); 2.60 (s, 12H, 2 NMe2), 1.68 (s, 6H,
C(3,5)–CH3), 1.16 (m, 4H, 2 CH2–CH3), 0.78 (t, 6H,
J7.5 Hz, 2 CH2–CH3).
1H, J1.4 Hz, H-4), 6.94 (s, 1H, H-6), 2.48 (s, 3H, CH3).
3-Methyl-1,8-diaza-9,10-anthraquinone (22). Starting
from 117 mg (0.44 mmol) of 2,6-dibromobenzoquinone,
42 mg (1 equiv.) of the azadiene 8 and then 51 mg
(1.2 equiv.) of the azadiene 9, a yield of 89 mg (91%) of
compound 22 was obtained, as an off-white solid. [Found:
C, 69.32; H, 3.79; N, 12.29. C13H8N2O2 requires C, 69.63;
H, 3.59; N, 12.49]; mp 298–301ЊC; nmax (KBr) 1698 and
1673 cmϪ1. dH (CDCl3, 250 MHz) 9.16–9.12 (m, 1H, H-7),
8.95 (d, 1H, J1.7 Hz, H-2), 8.65–8.59 (m, 1H, H-5), 8.39
(d, 1H, J1.2 Hz, H-4), 7.80–7.72 (m, 1H, H-6), 2.56 (s,
3H, C3–CH3). dC (CDCl3, 63 MHz) 182.5 (C-9), 180.1
(C-10), 156.6 and 155.70 (C-2 and C-7), 148.9 (C-8a),
146.80 (C-9a), 139.6 (C-3), 135.3 and 134.9 (C-4 and
C-5), 130.04 (C-10a), 129.61 (C-4a), 128.3 (C-6), 19.1
(C3–CH3).
4,5-Dimethyl-1,8-diazaanthraquinone (18). Starting from
235 mg (0.72 mmol) of compound 16, a yield of 146 mg
(85%) of compound 18 was obtained. [Found: C, 70.67;
H, 4.20; N, 11.76. C14H10N2O2 requires C, 70.58; H, 4.20;
N, 11.76]; mp 245–247ЊC; nmax (KBr) 1670.2 cmϪ1. dH
(CDCl3, 250 MHz) 8.89 (d, 2H, J4.8 Hz, H-2,7), 7.49 (d,
2H, J4.8 Hz, H-3,5); 2.56 (s, 6H, 2 CH3). dC (CDCl3,
63 MHz) 186.5 (C-9); 181.1 (C-10); 153.6 (C-2,7); 151.2
(C-8a,9a); 150.4 (C-4,5); 131.7 (C-3,6); 129.9 (C-4a,10a);
22.5 (2 CH3).
4,5-Diethyl-3,6-dimethyl-1,8-diazaanthraquinone (19).
Starting from 286 mg (0.74 mmol) of compound 16, an
yield of 175 mg (80%) of compound 19 was obtained.
[Found: C, 73.17; H, 5.98; N, 9.43. C18H18N2O2 requires
C, 73.46; H, 6.12; N, 9.52]; mp 165–167ЊC; nmax (KBr)
1671.3 cmϪ1. dH (CDCl3, 250 MHz) 8.76 (s, 2H, H-2,7),
3.13 (q, 4H, J7.7 Hz, 2 CH2–CH3), 2.49 (s, 6H, 2 CH3),
1.33 (t, 6H, J7.7 Hz, 2 CH2–CH3); dC (CDCl3, 63 MHz)
182.9 (C-9); 180.1 (C-10); 155.0 (C-2,7); 153.8 (C-8a,9a);
147.5 (C-4,5); 138.5 (C-3,6); 130.5 (C-4a,10a); 23.4 (CH2–
CH3); 16.9 (C(4)–CH3); 13.5 (CH2–CH3).
3-Ethyl-6-methyl-1,8-diaza-9,10-anthraquinone
(23).
Starting from 115 mg (0.43 mmol) of 2,6-dibromobenzo-
quinone, 48 mg (1 equiv.) of azadiene 9 and then 44 mg
(1.2 equiv.) of azadiene 5, a yield of 42 mg (39%) of
compound 23 was obtained, as an off-white solid. [Found:
C, 71.13; H, 4.68; N, 10.97. C15H12N2O2 requires C, 71.41;
H, 4.79; N, 11.10]; mp 245–247ЊC; nmax (KBr) 1693 and
1667 cmϪ1. dH (CDCl3, 250 MHz) 8.95–8.93 (m, 1H,
H-2,7), 8.39–8.37 (m, 1H, H-4,5), 2.86 (q, 2H, J7.6 Hz,
C3–CH2–CH3), 2.55 (s, 3H, C6–CH3), 1.35 (t, 3H,
J7.6 Hz, C3–CH2–CH3). dC (CDCl3, 63 MHz) 182.9
(C-9), 180.1 (C-10), 156,5 and 155.9 (C-2 and C-7), 147.0
and 146.8 (C-8a and C-9a), 145.3 (C-3), 139.4 (C-6), 135.1
and 133.9 (C-4 and C-5), 129.8 and 129.6 (C-4a and C-10a),
26.5 (C3–CH2–CH3), 19.1 (C6–CH3), 14.7 (C3–CH2–CH3).
Preparation of unsymmetrical 1,8-diaza-9,10-anthra-
quinones: general procedures
A suspension of 2,6-dibromobenzoquinone in (ClCH2)2
(40 mL per 100 mg of dibromobenzoquinone) was stirred
at 110ЊC for 15 min. To the solution thus obtained was
3-n-Butyl-6-methyl-1,8-diaza-9,10-anthraquinone (24).
Starting from 75 mg (0.28 mmol) of 2,6-dibromobenzo-
quinone, 32 mg (1 equiv.) of azadiene 9 and then 35 mg
(1.2 equiv.) of azadiene 10, a yield of 34 mg (43%) of
compound 24 was obtained, as an off-white solid. [Found:
C, 72.60; H, 5.58; N, 9.66. C17H16N2O2 requires C, 72.84; H,
5.75; N, 9.99; mp 168–170ЊC; nmax (KBr) 1694 and
1665 cmϪ1; dH (CDCl3, 250 MHz) 8.92 (br. s, 2H, H-2,7),
8.36 (br. s, 2H, H-4,5), 2.80 (t, 2H, J7.6 Hz, C3–CH2–
CH2–CH2–CH3), 2.55 (s, 3H, C6–CH3), 1.68 (m, 2H, C3–
CH2–CH2–CH2–CH3), 1.38 (m, 2H, C3–CH2–CH2–CH2–
CH3), 0.93 (t, 3H, J7.3 Hz, C3–CH2–CH2–CH2–CH3); dC
(CDCl3, 63 MHz) 182.9 (C-9), 180.1 (C-10), 156,4 and
156.2 (C-2 and C-7), 147.0 and 146.9 (C-8a and C-9a),
144.15 (C-3), 139.4 (C-6), 135.1 and 134.3 (C-4 and C-5),
129.7 and 129.6 (C-4a and C-10a), 33.1 (C3–CH2–CH2–
CH2–CH3), 32.8 (C3–CH2–CH2–CH2–CH3), 22.35 (C3–
CH2–CH2–CH2–CH3), 19.09 (C6–CH3), 13.88 (C3–CH2–
CH2–CH2–CH3).
added
a solution of acrolein dimethylhydrazone 8
(1 equiv.) or methacrolein dimethylhydrazone 9 (1 equiv.)
in (ClCH2)2 (10 mL), dropwise over 1 h. The solution was
stirred at that temperature for 1 h, and an additional amount
of 0.1 equiv. of the azadiene was added. After further
30 min at 110ЊC, the reaction mixture was cooled and
evaporated. The residue was dissolved in ethyl acetate
(10 mL) and filtered through a pad of silica gel. Evaporation
of the solvent afforded a residue, which was characterized
by 1H NMR spectroscopy as the virtually pure 7-bromo-5,8-
quinolinequinone 20 or 7-bromo-3-methyl-5,8-quinoline-
quinone 21, which were immediately used without further
purification.
To a solution of 20 or 21 in CHCl3 (5 mL) was added the
appropriate second azadiene (1.2 equiv.). The solution was
stirred at room temperature for 12 h (24 h in the preparation
of compound 26) and evaporated. The residue was chroma-
tographed (AcOEt), yielding compounds 22–26 as off-
white, pale yellow or pale brown solids.
3,5-Dimethyl-1,8-diaza-9,10-anthraquinone (25). Starting
from 117 mg (0.44 mmol) of 2,6-dibromobenzoquinone,
49 mg (1 equiv.) of azadiene 9 and then 59 mg (1.2 equiv.)
of azadiene 11, a yield of 36 mg (35%) of compound 25
7-bromo-5,8-quinolinequinone
(20).
dH
(CDCl3,
250 MHz) 9.05 (dd, 1H, J4.7 and 1.7 Hz, H-2), 8.46 (dd,